380 related articles for article (PubMed ID: 16282325)
1. Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases.
Samuel T; Welsh K; Lober T; Togo SH; Zapata JM; Reed JC
J Biol Chem; 2006 Jan; 281(2):1080-90. PubMed ID: 16282325
[TBL] [Abstract][Full Text] [Related]
2. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
Garrison JB; Samuel T; Reed JC
Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
[TBL] [Abstract][Full Text] [Related]
3. Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic.
Cossu F; Milani M; Vachette P; Malvezzi F; Grassi S; Lecis D; Delia D; Drago C; Seneci P; Bolognesi M; Mastrangelo E
PLoS One; 2012; 7(11):e49527. PubMed ID: 23166698
[TBL] [Abstract][Full Text] [Related]
4. The inhibitor of apoptosis protein fusion c-IAP2.MALT1 stimulates NF-kappaB activation independently of TRAF1 AND TRAF2.
Varfolomeev E; Wayson SM; Dixit VM; Fairbrother WJ; Vucic D
J Biol Chem; 2006 Sep; 281(39):29022-9. PubMed ID: 16891304
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
Welsh K; Milutinovic S; Ardecky RJ; Gonzalez-Lopez M; Ganji SR; Teriete P; Finlay D; Riedl S; Matsuzawa S; Pinilla C; Houghten R; Vuori K; Reed JC; Cosford ND
PLoS One; 2016; 11(9):e0161952. PubMed ID: 27617834
[TBL] [Abstract][Full Text] [Related]
6. Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein.
Fu J; Jin Y; Arend LJ
J Biol Chem; 2003 Dec; 278(52):52660-72. PubMed ID: 14523016
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric recruitment of cIAPs by TRAF2.
Mace PD; Smits C; Vaux DL; Silke J; Day CL
J Mol Biol; 2010 Jul; 400(1):8-15. PubMed ID: 20447407
[TBL] [Abstract][Full Text] [Related]
8. Neuronal apoptosis-inhibitory protein does not interact with Smac and requires ATP to bind caspase-9.
Davoodi J; Lin L; Kelly J; Liston P; MacKenzie AE
J Biol Chem; 2004 Sep; 279(39):40622-8. PubMed ID: 15280366
[TBL] [Abstract][Full Text] [Related]
9. Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization.
Feltham R; Bettjeman B; Budhidarmo R; Mace PD; Shirley S; Condon SM; Chunduru SK; McKinlay MA; Vaux DL; Silke J; Day CL
J Biol Chem; 2011 May; 286(19):17015-28. PubMed ID: 21393245
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
[TBL] [Abstract][Full Text] [Related]
11. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
[TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.
Darding M; Feltham R; Tenev T; Bianchi K; Benetatos C; Silke J; Meier P
Cell Death Differ; 2011 Aug; 18(8):1376-86. PubMed ID: 21331077
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of Smac/Diablo by inhibitors of apoptosis (IAPs). A caspase-independent mechanism for apoptotic inhibition.
Wilkinson JC; Wilkinson AS; Scott FL; Csomos RA; Salvesen GS; Duckett CS
J Biol Chem; 2004 Dec; 279(49):51082-90. PubMed ID: 15371416
[TBL] [Abstract][Full Text] [Related]
14. IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition.
Armstrong MJ; Stang MT; Liu Y; Yan J; Pizzoferrato E; Yim JH
Cancer Biol Ther; 2015; 16(7):1029-41. PubMed ID: 26011589
[TBL] [Abstract][Full Text] [Related]
15. The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases.
Eckelman BP; Salvesen GS
J Biol Chem; 2006 Feb; 281(6):3254-60. PubMed ID: 16339151
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2.
Alvarez SE; Harikumar KB; Hait NC; Allegood J; Strub GM; Kim EY; Maceyka M; Jiang H; Luo C; Kordula T; Milstien S; Spiegel S
Nature; 2010 Jun; 465(7301):1084-8. PubMed ID: 20577214
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
[TBL] [Abstract][Full Text] [Related]
18. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
Bockbrader KM; Tan M; Sun Y
Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
[TBL] [Abstract][Full Text] [Related]
19. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway.
Srinivasula SM; Datta P; Fan XJ; Fernandes-Alnemri T; Huang Z; Alnemri ES
J Biol Chem; 2000 Nov; 275(46):36152-7. PubMed ID: 10950947
[TBL] [Abstract][Full Text] [Related]
20. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ.
Arnt CR; Chiorean MV; Heldebrant MP; Gores GJ; Kaufmann SH
J Biol Chem; 2002 Nov; 277(46):44236-43. PubMed ID: 12218061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
